Welcome to the international HTA database

Showing [16861 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2013	HAYES, Inc.	Administration of pegfilgrastim (Neulasta; Amgen Inc.) on the same day as chemotherapy
2013	HAYES, Inc.	Whole exome sequencing for cancer indications
2013	Health Quality Ontario (HQO)	Relationship of patient volume and stroke outcomes: a rapid review
2013	HAYES, Inc.	Kabuki syndrome
2013	HAYES, Inc.	Computed Tomography (CT)-guided lung biopsy with the superDimension i-Logic System (Covidien)
2013	HAYES, Inc.	Whole exome sequencing for noncancer indications
2013	Health Quality Ontario (HQO)	Action plans for individuals with chronic obstructive pulmonary disease (COPD): a rapid review
2013	NIHR Health Technology Assessment programme	Home telemonitoring or structured telephone support programmes after recent discharge in patients with heart failure: systematic review and economic evaluation
2013	HAYES, Inc.	PreOvar KRAS-variant test for ovarian cancer
2013	HAYES, Inc.	Disinfection caps with isopropyl alcohol-impregnated sponges for needleless connectors to reduce central line-associated bloodstream infections
2013	HAYES, Inc.	Oncotype DX colon cancer assay
2013	Health Quality Ontario (HQO)	Inhospital physiotherapy for acute exacerbations of chronic obstructive pulmonary disease (AECOPD): a rapid review
2013	HAYES, Inc.	C-leg prostheses (Otto Bock HealthCare LP) for patients with above-knee amputation
2013	HAYES, Inc.	Endoloop ligature (Ethicon Endo-Surgery Inc.) for appendiceal stump closure during laparoscopic appendectomy
2013	HAYES, Inc.	Acupuncture for treatment of Chronic Obstructive Pulmonary Disease (COPD)
2013	Health Quality Ontario (HQO)	B-type natriuretic peptide testing: a rapid review
2013	NIHR Health Technology Assessment programme	Systematic review of the psychological consequences of false-positive screening mammograms
2013	HAYES, Inc.	Coflex interlaminar stabilization device (Paradigm Spine LLC) for treatment of lumbar spinal stenosis
2013	HAYES, Inc.	Humira (Adalimumab; Abbott Laboratories) for treatment of pediatric crohn's disease
2013	HAYES, Inc.	In-hospital patient bathing with 2% chlorhexidine gluconate cloths (Sage Products Inc.) for prevention of hospital-acquired infections
2013	Health Quality Ontario (HQO)	Chest X-rays for diagnosing pulmonary infection as a precipitant of acute heart failure: a rapid review
2012	NIHR Horizon Scanning Centre (NIHR HSC)	CT-P13 (Infliximab biosimilar) for rheumatoid arthritis
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Rilonacept for gout
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Tocilizumab (RoActemra) for active polyarticular juvenile idiopathic arthritis – second line
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Pitolisant for hypersomnia and narcolepsy in patients with Parkinson's disease
2012	NIHR Health Technology Assessment programme	Exercise interventions for the management of health related quality of life and fatigue in cancer survivors during and after treatment
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Davunetide intranasal for progressive supranuclear palsy – first line
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Dexpramipexole for amyotrophic lateral sclerosis
2012	Agency for Healthcare Research and Quality (AHRQ)	Systematic review of decision tools and their suitability for patient-centered decisionmaking regarding electronic cardiac devices
2012	Belgian Health Care Knowledge Centre (KCE)	Belgian guidelines for economic evaluations and budget impact analyses: second edition
2012	NIHR Horizon Scanning Centre (NIHR HSC)	UPDATED: Placental growth factor based tests for the diagnosis of pre-eclampsia
2012	NIHR Horizon Scanning Centre (NIHR HSC)	UPDATED: DuoFertility ovulation prediction system to aid natural conception
2012	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Eplerenone (Inspra) 25mg and 50mg film-coated tablets
2012	NIHR Horizon Scanning Centre (NIHR HSC)	UPDATED: VERV™ patient managed transdermal neuromodulation system for overactive bladder syndrome
2012	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Sildenafil (Revatio) 10mg/ml powder for oral suspension
2012	NIHR Horizon Scanning Centre (NIHR HSC)	RePneu™ lung volume reduction coils for emphysema
2012	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Bortezomib (Velcade®) 3.5 mg subcutaneous injection
2012	NIHR Horizon Scanning Centre (NIHR HSC)	WOUNDCHEK™ Protease status point of care test for chronic wounds
2012	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Argatroban (Exembol®) 100 mg/ml concentrate for solution for infusion
2012	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[DETECTA-T]
2012	Institute for Clinical Evaluative Sciences (ICES)	Health outcomes for better information and care (HOBIC): acute care in Ontario
2012	Institute for Clinical Evaluative Sciences (ICES)	Ontario stroke evaluation report 2012: prescribing system solutions to improve stroke outcomes
2012	Institute for Clinical Evaluative Sciences (ICES)	Hospital care for all: an equity report on differences in household income among patients at Toronto Central Local Health Integration Network (TC LHIN) hospitals, 2008-2010
2012	Health Council of the Netherlands Gezondheidsraad (GR)	The mental health of young migrants and their uptake of care
2012	Institute for Clinical Evaluative Sciences (ICES)	Seven more years: the impact of smoking, alcohol, diet, physical activity and stress on health and life expectancy in Ontario
2012	Health Council of the Netherlands Gezondheidsraad (GR)	New anticoagulants: a well-dosed introduction
2012	Institute for Clinical Evaluative Sciences (ICES)	Regional measures of diabetes burden in Ontario
2012	Health Council of the Netherlands Gezondheidsraad (GR)	Perspectives on oral health care
2012	Institute for Clinical Evaluative Sciences (ICES)	Comparison of primary care models in Ontario by demographics, case mix and emergency department use, 2008/09 to 2009/10
2012	Institute for Clinical Evaluative Sciences (ICES)	Payments to Ontario physicians from ministry of health and long-term care sources, 1992/93 to 2009/10
2012	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Lenalidomide (Revlimid®) for the treatment of low /intermediate-1 risk myelodysplastic syndrome with chromosome 5q deletion
2012	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Brentuximab (Adcetris®) for the treatment of relapsed Hodgkin's lymphoma (HL) or relapsed systemic anaplastic large cell lymphoma (sALCL)
2012	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Romidepsin (Istodax®) for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL) after prior systemic therapy
2012	Technology Assessment at SickKids (TASK)	The use of biologic response modifiers in polyarticularcourse juvenile idiopathic arthritis - a systematic review update
2012	Penn Medicine Center for Evidence-based Practice (CEP)	Outcomes associated with long-term acute care hospitals
2012	Penn Medicine Center for Evidence-based Practice (CEP)	Guidelines for admission to long-term acute care hospitals
2012	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Microbial sealant to reduce surgical site infections following coronary artery bypass graft
2012	Penn Medicine Center for Evidence-based Practice (CEP)	Specialized neurocritical care units for traumatic brain injury
2012	Penn Medicine Center for Evidence-based Practice (CEP)	Screening tests for aspiration and dysphagia
2012	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Percutaneous repair of mitral regurgitation with the MitraClip]
2012	Penn Medicine Center for Evidence-based Practice (CEP)	Best practices for preventing aspiration pneumonia in hospitalized patients
2012	Penn Medicine Center for Evidence-based Practice (CEP)	Guidelines for platelet or plasma transfusion in lumbar puncture patients
2012	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Impact evaluation and environmental analysis
2012	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Ipilimumab (Yervoy®) for the first-line therapy of advanced/metastatic cutaneous melanoma
2012	HAYES, Inc.	Afirma® thyroid FNA analysis
2012	Penn Medicine Center for Evidence-based Practice (CEP)	CT for acute chest pain
2012	HAYES, Inc.	Anaplastic lymphoma kinase (ALK) gene rearrangement testing in non-small cell lung cancer (NSCLC)
2012	Institute for Clinical Evaluative Sciences (ICES)	Opening eyes, opening minds: the Ontario burden of mental illness and addictions report
2012	NIHR Health Technology Assessment programme	A pragmatic randomised controlled trial to evaluate the cost-effectiveness of a physical activity intervention as a treatment for depression: the treating depression with physical activity (TREAD) trial
2012	Penn Medicine Center for Evidence-based Practice (CEP)	Bone morphogenetic proteins and bone marrow aspirate concentrate for tibial fractures and long bone nonunions
2012	HAYES, Inc.	Fibrinogen-beta (FGB) c.-455G>A polymorphism testing in cardiovascular disease
2012	NIHR Health Technology Assessment programme	Outcomes of social care for adults: developing a preference weighted measure
2012	Penn Medicine Center for Evidence-based Practice (CEP)	Comparative effectiveness of devices for detection of respiratory distress in post-operative patients
2012	Penn Medicine Center for Evidence-based Practice (CEP)	Hyperthermic intraperitoneal chemotherapy
2012	HAYES, Inc.	Cognitive-behavioral therapy for bulimia nervosa
2012	HAYES, Inc.	Harmony™ Prenatal Test
2012	Penn Medicine Center for Evidence-based Practice (CEP)	Electromagnetically-assisted feeding tube placement
2012	HAYES, Inc.	Coronary artery calcium scoring to assess the risk of coronary artery disease in asymptomatic adults
2012	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Bortezomib (Velcade®) as consolidation or maintenance therapy after autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma
2012	HAYES, Inc.	Mammostrat® for prognosis of breast cancer recurrence
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Sebelipase alfa for lysosomal acid lipase deficiency
2012	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Everolimus (Afinitor® or Votubia®) in combination with exemestane in postmenopausal women with oestrogen receptor positive, HER2- negative locally advanced or metastatic breast cancer who are refractory to letrozole or anastrozole
2012	HAYES, Inc.	Multiple endocrine neoplasia type 2 (MEN2)
2012	HAYES, Inc.	Custom total knee arthroplasty
2012	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Pertuzumab (Omnitarg/Perjeta®) for the first-line therapy of metastatic HER2 positive breast cancer
2012	HAYES, Inc.	Thyroid hormone receptor beta (THRB) gene testing in resistance to thyroid hormone (RTH)
2012	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Rilpivirine (Edurant®)
2012	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Rifaximin (Xifaxanta®)
2012	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Nevirapine (Viramune®)
2012	Health Information and Quality Authority (HIQA)	Health technology assessment of a national deep brain stimulation service in Ireland
2012	The Regional Health Technology Assessment Centre (HTA-centrum)	Diagnostic agreement of digital whole slide imaging and routine light microscopy
2012	The Regional Health Technology Assessment Centre (HTA-centrum)	Vitamin D supplementation in patients with active or latent tuberculosis
2012	The Regional Health Technology Assessment Centre (HTA-centrum)	Prosthetic arthroplasty in primary shoulder osteoarthritis
2012	Medical Advisory Secretariat (MAS)	Specialized community-based care: an evidence-based analysis
2012	The Regional Health Technology Assessment Centre (HTA-centrum)	Intraoperative cortical stimulation in brain tumor surgery
2012	NIHR Health Technology Assessment programme	Vemurafenib for the treatment of locally advanced or metastatic BRAF V600E mutation positive malignant melanoma
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Recombinant human N-acetylgalactosamine-6-sulfatase (rhGALNS) for mucopolysaccharidosis type IVA – first line
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Fostamatinib for rheumatoid arthritis – second line
2012	Institute of Health Economics (IHE)	First and second trimester prenatal screening for trisomies 13, 18, and 21 and open neural tube defects
2012	The Regional Health Technology Assessment Centre (HTA-centrum)	Timing of umbilical cord clamping for neonatal and maternal outcomes